European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Difficulties and inequities in access to homologous recombination deficiency testing in ovarian cancer patients
Difficulties and inequities in access to homologous recombination deficiency testing in ovarian cancer patients
DOI: 10.22514/ejgo.2024.042
Association between delayed initiation of treatment indications and survival in patients with cervical cancer: a systematic review and meta-analysis
Association between delayed initiation of treatment indications and survival in patients with cervical cancer: a systematic review and meta-analysis
DOI: 10.22514/ejgo.2024.043
Buddy operating in gynaecological oncology surgery: a large UK cancer centre's experience
Buddy operating in gynaecological oncology surgery: a large UK cancer centre's experience
DOI: 10.22514/ejgo.2024.046
Metabolism related gene signature predicts prognosis and indicates tumor immune infiltration in ovarian cancer
Metabolism related gene signature predicts prognosis and indicates tumor immune infiltration in ovarian cancer
DOI: 10.22514/ejgo.2024.040
CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model
CpG methylation of the PAX1 promoter in exfoliated cervical cells: a potential cervical cancer screening model
DOI: 10.22514/ejgo.2024.047
Comparing women senior leadership positions in gynaecologic oncology in Israel and the United States, a cross-sectional study
Comparing women senior leadership positions in gynaecologic oncology in Israel and the United States, a cross-sectional study
DOI: 10.22514/ejgo.2024.048
Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2
Taraxasterol inhibits cell proliferation and angiogenesis in ovarian cancer by targeting EphA2
DOI: 10.22514/ejgo.2024.049
Efficacy and safety of anlotinib combined with chemotherapy in the treatment of metastatic triple negative breast cancer
Efficacy and safety of anlotinib combined with chemotherapy in the treatment of metastatic triple negative breast cancer
DOI: 10.22514/ejgo.2024.050
Next generation sequencing analysis of BRCA1/2 genes reveals clinically significant pathogenic mutations in ovarian cancer patients
Next generation sequencing analysis of BRCA1/2 genes reveals clinically significant pathogenic mutations in ovarian cancer patients
DOI: 10.22514/ejgo.2024.051
Overexpression of URG11 can inhibit the proliferation and motility of breast cancer cells
Overexpression of URG11 can inhibit the proliferation and motility of breast cancer cells
DOI: 10.22514/ejgo.2024.052
Knockdown of GDF15 inhibits endometrial cancer cell proliferation and EMT
Knockdown of GDF15 inhibits endometrial cancer cell proliferation and EMT
DOI: 10.22514/ejgo.2024.053
Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia
Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia
DOI: 10.22514/ejgo.2024.001
Polygonatum sibiricum polysaccharide inhibits the proliferation of endometrial cancer cells by promoting cell death
Polygonatum sibiricum polysaccharide inhibits the proliferation of endometrial cancer cells by promoting cell death
DOI: 10.22514/ejgo.2024.054
Effects of Chinese medicine comprehensive care combined with art painting therapy in upper limb lymphedema and shoulder joint mobility after breast cancer surgery
Effects of Chinese medicine comprehensive care combined with art painting therapy in upper limb lymphedema and shoulder joint mobility after breast cancer surgery
DOI: 10.22514/ejgo.2024.056
Primary vs. interval cytoreduction for high-grade serous ovarian cancer: oncological outcomes from a retrospective study at a single tertiary referral center
Primary vs. interval cytoreduction for high-grade serous ovarian cancer: oncological outcomes from a retrospective study at a single tertiary referral center
DOI: 10.22514/ejgo.2024.057
Study on diagnostic efficacy of combined detection of serum CCL-18, p185 and SDF-1 in breast cancer
Study on diagnostic efficacy of combined detection of serum CCL-18, p185 and SDF-1 in breast cancer
DOI: 10.22514/ejgo.2024.058
Unraveling the mystery of uterine cotyledonoid dissecting leiomyoma: a case report
Unraveling the mystery of uterine cotyledonoid dissecting leiomyoma: a case report
DOI: 10.22514/ejgo.2024.060
Enhanced sonographic depiction of the distal fallopian tube: preliminary findings using a new volumetric technique
Enhanced sonographic depiction of the distal fallopian tube: preliminary findings using a new volumetric technique
DOI: 10.22514/ejgo.2024.061
Published Ahead of Print
Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic
Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic
Online publish date: 08 May 2024
DOI: 10.22514/ejgo.2024.041
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Online publish date: 12 October 2023
DOI: 10.22514/ejgo.2023.073
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Vulvar cancer in young woman—case report
Vulvar cancer in young woman—case report
Online publish date: 07 September 2023
DOI: 10.22514/ejgo.2023.070
Prognostic value of Ki-67 in patients with ovarian cancer
Prognostic value of Ki-67 in patients with ovarian cancer
Online publish date: 24 July 2023
DOI: 10.22514/ejgo.2023.051
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.